FDA Sodium Reduction Targets and the Food Industry: Are There Incentives to Reformulate? Microsimulation Cost‐Effectiveness Analysis

POLICY POINTS: The World Health Organization has recommended sodium reduction as a “best buy” to prevent cardiovascular disease (CVD). Despite this, Congress has temporarily blocked the US Food and Drug Administration (FDA) from implementing voluntary industry targets for sodium reduction in process...

Descrizione completa

Salvato in:
Dettagli Bibliografici
Pubblicato in:Milbank Q
Autori principali: COLLINS, BRENDAN, KYPRIDEMOS, CHRIS, PEARSON‐STUTTARD, JONATHAN, HUANG, YUE, BANDOSZ, PIOTR, WILDE, PARKE, KERSH, ROGAN, CAPEWELL, SIMON, MOZAFFARIAN, DARIUSH, WHITSEL, LAURIE P., MICHA, RENATA, O'FLAHERTY, MARTIN
Natura: Artigo
Lingua:Inglês
Pubblicazione: John Wiley and Sons Inc. 2019
Soggetti:
Original Scholarship
Accesso online:https://ncbi.nlm.nih.gov/pmc/articles/PMC6739614/
https://ncbi.nlm.nih.gov/pubmed/31332837
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1111/1468-0009.12402
Tags: Aggiungi Tag
Nessun Tag, puoi essere il primo ad aggiungerne! !

Documenti analoghi